Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3311 results

Sort By:

Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients

Study ID: NCT06648720
Start Date: 2025-03-01
End Date: 2029-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

3566

Intervention / Treatment

DAPT de-escalation

Sponsor

University Medical Center Ho Chi Minh City (UMC)

Source: clinicaltrials.gov

Share:
Add to list

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Study ID: NCT05377320
Start Date: 2025-06
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Clinical Decision Aid

Standard Care

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People with Serious Mental Illness

Study ID: NCT06641726
Start Date: 2025-01-01
End Date: 2035-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50000

Intervention / Treatment

Not applicable- observational study

Sponsor

Akrivia Healti

Source: clinicaltrials.gov

Share:
Add to list

Machine Learning and 3D Image-Based Modeling for Real-Time Body Weight and Body Composition Estimation During Emergency Medical Care. Study 1

Study ID: NCT06646120
Start Date: 2025-07-01
End Date: 2026-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment
Sponsor

Florida Atlantic University

Source: clinicaltrials.gov

Share:
Add to list

Reducing Falls with Varenicline in Hypocholinergic Parkinson Disease

Study ID: NCT06679374
Start Date: 2025-02
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

Placebo

Varenicline

Sponsor

Vikas Kotagal

Source: clinicaltrials.gov

Share:
Add to list

Interactive Design of Patient-Specific Molds for Tissue Shaping

Study ID: NCT06711965
Start Date: 2025-05-01
End Date: 2030-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Standard of care reconstruction

Surgery, Breast Mold

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM

Study ID: NCT06352866
Start Date: 2025-01-01
End Date: 2025-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Siltuximab

Teclistamab(FDA-approved)

Sponsor

Jack Khouri

Source: clinicaltrials.gov

Share:
Add to list

Romosozumab As an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea

Study ID: NCT06533865
Start Date: 2025-01
End Date: 2029-06-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

114

Intervention / Treatment

Romosozumab

Placebo

Zoledronic acid

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effect of Neurotization on QoL and Sensory Restoration

Study ID: NCT05206565
Start Date: 2025-03
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Neurotization - Autologous Reconstruction with DIEP/TRAM

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

Study ID: NCT06290765
Start Date: 2025-01-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

70

Intervention / Treatment

Ropeginterferon alfa-2b

Phlebotomy and aspirin

Sponsor

PharmaEssentia

Source: clinicaltrials.gov

Share:
Add to list